Position history for B. Metzler seel. Sohn & Co. AG's holdings in VERTEX PHARMACEUTICALS INC
B. Metzler seel. Sohn & Co. AG holds 511,036 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $228.2M as of 2026-Q1. The position was decreased (-0.8% shares). VRTX represents 2.1% of B. Metzler seel. Sohn & Co. AG's portfolio.
Current Value
$228.2M
Current Shares
511,036
Total Value Change
+$211.7M
Total Shares Change
+475,801
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 511,036 |
-0.8% |
| $228.2M |
| 2.1% |
| $474.27 |
0 |
| 2025-Q4 | Increased | 515,269 | +63.4% | $233.6M | 2.0% | $453.74 | 77 |
| 2025-Q3 | Decreased | 315,422 | -1.3% | $123.5M | 1.1% | $395.31 | 0 |
| 2025-Q2 | Increased | 319,621 | +1.7% | $142.3M | 1.4% | $441.30 | 48 |
| 2025-Q1 | Increased | 314,343 | +289.2% | $152.4M | 1.6% | $492.69 | 77 |
| 2024-Q4 | Increased | 80,759 | +101.9% | $32.4M | 0.3% | $399.35 | 56 |
| 2024-Q3 | Increased | 39,993 | +13.5% | $18.6M | 0.2% | $462.88 | 38 |
| 2024-Q2 | Increased | 35,235 | +126.8% | $16.5M | 0.2% | $468.72 | 54 |